跳至主要内容
临床试验/NCT02679781
NCT02679781已完成不适用

Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2017年3月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
1
主要终点
Number of Participants Compliant With Oral or Nasal Midazolam Administration

研究概览

简要总结

The general objective of the study is to compare the efficacy of administering midazolam orally as syrup versus nasally with nasal atomizer. The specific objectives are to measure: 1) acceptability of the medication, 2) effect on behavior, 3) time of onset, 4) maximum working time.

详细描述

  • Prospective, parallel design
  • Study and control group: 100 healthy children (ASA 1), ages: 2-6 years, uncooperative (Frankl 1-2), that needs at least two similar dental treatments. Exclusion criteria: enlarged tonsils (Brodsky's grading scale11 +3 = 50-75% airway obstruction, and +4 = >75% airway obstruction), upper respiratory tract infection or nasal discharge.
  • Randomization: At the first appointment the subjects will assigned randomly to receive oral midazolam or nasal midazolam;
  • Sedation: oral midazolam dose is 0.5mg/kg. Nasal midazolam dose is 0.2mg/kg. During treatment 50% nitrous oxide/ 50% oxygen will be administered via nasal hood.
  • Acceptability of the medication: compliance in taking the medication will be assessed and recorded as: willingly, coaxed, forced, or failed (not administered).
  • Behavior during dental treatment: Houpt scale measures behavior by rating sleep, movement, crying and overall behavior. The degree of alertness, movement and crying will be assessed before, during (every 5 min) and after the operative procedure. The rating will be done by one observer blind to the route of administration. This blind observer will also monitor the pulse and oxygen saturation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
2 Years 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • healthy children (ASA 1), uncooperative (Frankl 1-210), that needs at least two similar dental treatments.

排除标准

  • enlarged tonsils (Brodsky's grading scale11 +3 = 50-75% airway obstruction, and +4 = >75% airway obstruction), upper respiratory tract infection or nasal discharge.

研究组 & 干预措施

oral sedation

Active Comparator

administration of 0.5mg/kg oral midazolam. During dental treatment 50% nitrous oxide/ 50% oxygen will be administered via nasal hood.

干预措施: oral midazolam (Drug)

nasal sedation

Active Comparator

administration of 0.2mg/kg nasal midazolam. During dental treatment 50% nitrous oxide/ 50% oxygen will be administered via nasal hood.

干预措施: nasal midazolam (Drug)

结局指标

主要结局

Number of Participants Compliant With Oral or Nasal Midazolam Administration

时间窗: the compliance in taking the medication will be assessed at the time of administration and recorded immediately.

the compliance in taking the medication will be assessed at the time of administration by one of the investigators and recorded immediately as: willingly, coaxed, forced, or failed (not administered).

次要结局

  • Behavior During Dental Treatment(the effect of oral or nasal midazolam on behaviour will be assessed during dental treatment.The length of each treatment is estimated as 30-45 minutes.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Avia Fux

pediatric dentist

Hadassah Medical Organization

研究点 (1)

Loading locations...

相似试验

Nasal Versus Oral Midazolam Sedation in Routine... | 临床试验